Activation of cutaneous immune responses in complex regional pain syndrome

Journal of Pain

Volumn 15, Issue 5, 2014, Pages 485-495

  Birklein, Frank ^a   Drummond, Peter D ^b   Li, Wenwu ^c,d   Schlereth, Tanja ^a   Albrecht, Nahid ^a   Finch, Philip M ^b   Dawson, Linda F ^b   Clark, J David ^c,d   Kingery, Wade S ^d  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b MURDOCH UNIVERSITY   (Australia)

^c STANFORD UNIVERSITY   (United States)

^d VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Complex regional pain syndrome; immunology; keratinocytes; mast cells; pain

Indexed keywords

INTERLEUKIN 6; KI 67 ANTIGEN; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN;

ADULT; AGE; AGED; ALLODYNIA; ARTICLE; BLISTER; CELL COUNT; CELL PROLIFERATION; COMPLEX REGIONAL PAIN SYNDROME TYPE I; COMPLEX REGIONAL PAIN SYNDROME TYPE II; CONTROLLED STUDY; CYTOPLASM; DISEASE DURATION; EPIDERMIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INNATE IMMUNITY; KERATINOCYTE; LIMB FRACTURE; MAJOR CLINICAL STUDY; MALE; MAST CELL; MIDDLE AGED; PAIN ASSESSMENT; PROTEIN EXPRESSION; PUNCH BIOPSY; SKIN BIOPSY; SKIN TEMPERATURE; SKINFOLD THICKNESS; UPREGULATION; YOUNG ADULT; BIOPSY; COMPLEX REGIONAL PAIN SYNDROME; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; IMMUNOLOGY; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN;

ADULT; AGED; BIOPSY; CELL PROLIFERATION; COMPLEX REGIONAL PAIN SYNDROMES; EPIDERMIS; FEMALE; HUMANS; INTERLEUKIN-6; KERATINOCYTES; MALE; MAST CELLS; MIDDLE AGED; ORGAN SIZE; SKIN; SKIN PHYSIOLOGICAL PROCESSES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84899930569     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2014.01.490     Document Type: Article

References (47)

1. M. Bernateck, M. Karst, K.F. Gratz, G.J. Meyer, M.J. Fischer, W.H. Knapp, W. Koppert, and T. Brunkhorst The first scintigraphic detection of tumor necrosis factor-alpha in patients with complex regional pain syndrome type 1 Anesth Analg 110 2010 211 215
2. M. Bernateck, R. Rolke, F. Birklein, R.D. Treede, M. Fink, and M. Karst Successful intravenous regional block with low-dose tumor necrosis factor-alpha antibody infliximab for treatment of complex regional pain syndrome 1 Anesth Analg 105 2007 1148 1151
3. F. Birklein, B. Riedl, N. Sieweke, M. Weber, and B. Neundorfer Neurological findings in complex regional pain syndromes - Analysis of 145 cases Acta Neurol Scand 101 2000 262 269
4. S. Bruehl An update on the pathophysiology of complex regional pain syndrome Anesthesiology 113 2010 713 725
5. I. Carroll, J.D. Clark, and S. Mackey Sympathetic block with botulinum toxin to treat complex regional pain syndrome Ann Neurol 65 2009 348 351
6. R.F. De Jongh, K.C. Vissers, T.F. Meert, L.H. Booij, C.S. De Deyne, and R.J. Heylen The role of interleukin-6 in nociception and pain Anesth Analg 96 2003 1096 1103
7. M. de Mos, A.G. de Bruijn, F.J. Huygen, J.P. Dieleman, B.H. Stricker, and M.C. Sturkenboom The incidence of complex regional pain syndrome: A population-based study Pain 129 2007 12 20
8. M. Dirckx, G. Groeneweg, F. Wesseldijk, D.L. Stronks, and F.J. Huygen Report of a preliminary discontinued double-blind, randomized, placebo-controlled trial of the anti-TNF-alpha chimeric monoclonal antibody infliximab in complex regional pain syndrome Pain Pract 13 2013 633 640
9. E. Eisenberg, I. Sandler, R. Treister, E. Suzan, and M. Haddad Anti tumor necrosis factor-alpha adalimumab for complex regional pain syndrome type 1 (CRPS-I): A case series Pain Pract 13 2013 649 656
10. J. Gerdes, H. Lemke, H. Baisch, H.H. Wacker, U. Schwab, and H. Stein Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67 J Immunol 133 1984 1710 1715
11. J.G. Groeneweg, F.J. Huygen, C. Heijmans-Antonissen, S. Niehof, and F.J. Zijlstra Increased endothelin-1 and diminished nitric oxide levels in blister fluids of patients with intermediate cold type complex regional pain syndrome type 1 BMC Musculoskelet Disord 7 2006 91
12. T.Z. Guo, S.C. Offley, E.A. Boyd, C.R. Jacobs, and W.S. Kingery Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I Pain 108 2004 95 107
13. T.Z. Guo, T. Wei, and W.S. Kingery Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I Pain 121 2006 158 167
14. T.Z. Guo, T. Wei, X. Shi, W.W. Li, S. Hou, L. Wang, K. Tsujikawa, K.C. Rice, K. Cheng, D.J. Clark, and W.S. Kingery Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome Mol Pain 8 2012 85
15. E. Hansson Could chronic pain and spread of pain sensation be induced and maintained by glial activation? Acta Physiol 187 2006 321 327
16. R.N. Harden, S. Bruehl, M. Stanton-Hicks, and P.R. Wilson Proposed new diagnostic criteria for complex regional pain syndrome Pain Med 8 2007 326 331
17. C. Heijmans-Antonissen, F. Wesseldijk, R.J. Munnikes, F.J. Huygen, P. van der Meijden, W.C. Hop, H. Hooijkaas, and F.J. Zijlstra Multiplex bead array assay for detection of 25 soluble cytokines in blister fluid of patients with complex regional pain syndrome type 1 Mediators Inflamm 2006 2006 28398
18. S.C. Hoffmann, E.M. Stanley, E.D. Cox, B.S. DiMercurio, D.E. Koziol, D.M. Harlan, A.D. Kirk, and P.J. Blair Ethnicity greatly influences cytokine gene polymorphism distribution Am J Transplant 2 2002 560 567
19. F.J. Huygen, A.G. De Bruijn, M.T. De Bruin, J.G. Groeneweg, J. Klein, and F.J. Zijistra Evidence for local inflammation in complex regional pain syndrome type 1 Mediators Inflamm 11 2002 47 51
20. F.J. Huygen, S. Niehof, F.J. Zijlstra, P.M. van Hagen, and P.L. van Daele Successful treatment of CRPS 1 with anti-TNF J Pain Symptom Manage 27 2004 101 103
21. F.J. Huygen, N. Ramdhani, A. van Toorenenbergen, J. Klein, and F.J. Zijlstra Mast cells are involved in inflammatory reactions during Complex Regional Pain Syndrome type 1 Immunol Lett 91 2004 147 154
22. X. Jin, and R.W. Gereau 4th Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha J Neurosci 26 2006 246 255
23. M. Koltzenburg, P.D. Wall, and S.B. McMahon Does the right side know what the left is doing? Trends Neurosci 22 1999 122 127
24. H.H. Kramer, T. Eberle, N. Uceyler, I. Wagner, T. Klonschinsky, L.P. Muller, C. Sommer, and F. Birklein TNF-alpha in CRPS and "normal" trauma - Significant differences between tissue and serum Pain 152 2011 285 290
25. S. Leis, M. Weber, A. Isselmann, M. Schmelz, and F. Birklein Substance-P-induced protein extravasation is bilaterally increased in complex regional pain syndrome Exp Neurol 183 2003 197 204
26. W. Li, X. Shi, L. Wang, T. Guo, T. Wei, K. Cheng, K.C. Rice, W.S. Kingery, and J.D. Clark Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome Pain 154 2013 1224 1236
27. W.W. Li, T.Z. Guo, X.Q. Li, W.S. Kingery, and J.D. Clark Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators Pain 151 2010 843 852
28. W.W. Li, T.Z. Guo, D.Y. Liang, Y. Sun, W.S. Kingery, and J.D. Clark Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome Anesthesiology 116 2012 882 895
29. W.W. Li, I. Sabsovich, T.Z. Guo, R. Zhao, W.S. Kingery, and J.D. Clark The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome Pain 144 2009 303 313
30. J. Marinus, G.L. Moseley, F. Birklein, R. Baron, C. Maihofner, W.S. Kingery, and J.J. van Hilten Clinical features and pathophysiology of complex regional pain syndrome Lancet Neurol 10 2011 637 648
31. R.J. Munnikes, C. Muis, M. Boersma, C. Heijmans-Antonissen, F.J. Zijlstra, and F.J. Huygen Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines Mediators Inflamm 2005 2005 366 372
32. M. Paalani, J.W. Lee, E. Haddad, and S. Tonstad Determinants of inflammatory markers in a bi-ethnic population Ethn Dis 21 2011 142 149
33. S. Pezet, and S.B. McMahon Neurotrophins: Mediators and modulators of pain Annu Rev Neurosci 29 2006 507 538
34. I. Sabsovich, T.Z. Guo, T. Wei, R. Zhao, X. Li, D.J. Clark, C. Geis, C. Sommer, and W.S. Kingery TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I Pain 137 2008 507 519
35. I. Sabsovich, T. Wei, T.Z. Guo, R. Zhao, X. Shi, X. Li, D.C. Yeomans, M. Klyukinov, W.S. Kingery, and J.D. Clark Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I Pain 138 2008 47 60
36. J. Sandby-Moller, T. Poulsen, and H.C. Wulf Epidermal thickness at different body sites: Relationship to age, gender, pigmentation, blood content, skin type and smoking habits Acta Derm Venereol 83 2003 410 413
37. P. Sandroni, L.M. Benrud-Larson, R.L. McClelland, and P.A. Low Complex regional pain syndrome type I: Incidence and prevalence in Olmsted County, a population-based study Pain 103 2003 199 207
38. T. Scholzen, and J. Gerdes The Ki-67 protein: From the known and the unknown J Cell Physiol 182 2000 311 322
39. X. Shi, L. Wang, J.D. Clark, and W.S. Kingery Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1/2 and JNK MAPK transcription pathways Regul Pept 186 2013 92 103
40. T. Tanaka, B.J. McRae, K. Cho, R. Cook, J.E. Fraki, D.A. Johnson, and J.C. Powers Mammalian tissue trypsin-like enzymes. Comparative reactivities of human skin tryptase, human lung tryptase, and bovine trypsin with peptide 4-nitroanilide and thioester substrates J Biol Chem 258 1983 13552 13557
41. M.L. Usui, J.N. Mansbridge, W.G. Carter, M. Fujita, and J.E. Olerud Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds J Histochem Cytochem 56 2008 687 696
42. P. Vanderslice, S.M. Ballinger, E.K. Tam, S.M. Goldstein, C.S. Craik, and G.H. Caughey Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family Proc Natl Acad Sci U S A 87 1990 3811 3815
43. T. Wei, T.Z. Guo, W.W. Li, S. Hou, W. Kingery, and J.D. Clark Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain J Neuroinflammation 9 2012 181
44. T. Wei, W.W. Li, T.Z. Guo, R. Zhao, L. Wang, D.J. Clark, A.L. Oaklander, M. Schmelz, and W.S. Kingery Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I Pain 144 2009 278 286
45. T. Wei, I. Sabsovich, T.Z. Guo, X. Shi, R. Zhao, W. Li, C. Geis, C. Sommer, W.S. Kingery, and D.J. Clark Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome Eur J Pain 13 2009 253 262
46. F. Wesseldijk, F.J. Huygen, C. Heijmans-Antonissen, S.P. Niehof, and F.J. Zijlstra Six years follow-up of the levels of TNF-alpha and IL-6 in patients with complex regional pain syndrome type 1 Mediators Inflamm 469439 2008 2008
47. F. Wesseldijk, F.J. Huygen, C. Heijmans-Antonissen, S.P. Niehof, and F.J. Zijlstra Tumor necrosis factor-alpha and interleukin-6 are not correlated with the characteristics of Complex Regional Pain Syndrome type 1 in 66 patients Eur J Pain 12 2008 716 721